Related references
Note: Only part of the references are listed.Functional Characterization of 34 CYP2A6 Allelic Variants by Assessment of Nicotine C-Oxidation and Coumarin 7-Hydroxylation Activities
Hiroki Hosono et al.
DRUG METABOLISM AND DISPOSITION (2017)
Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters
Gabor J. Szebeni et al.
MEDIATORS OF INFLAMMATION (2017)
Application of bacterial reverse mutation assay for detection of non-genotoxic carcinogens
Rewan Kanode et al.
TOXICOLOGY MECHANISMS AND METHODS (2017)
Application of bacterial reverse mutation assay for detection of non-genotoxic carcinogens
Rewan Kanode et al.
TOXICOLOGY MECHANISMS AND METHODS (2017)
Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors
Julie-Anne Tanner et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity
Tsutomu Shimada
TOXICOLOGICAL RESEARCH (2017)
Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity
Mingming Zhao et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2017)
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis
Martyn T. Smith et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2016)
Flavour chemicals in electronic cigarette fluids
Peyton A. Tierney et al.
TOBACCO CONTROL (2016)
Interleukins 1 and 6 as main mediators of inflammation and cancer
O. S. Dmitrieva et al.
BIOCHEMISTRY-MOSCOW (2016)
Coumarin-Induced DNA Ligation, Rearrangement to DNA Interstrand Crosslinks, and Photorelease of Coumarin Moiety
Huabing Sun et al.
CHEMBIOCHEM (2016)
Celery extract inhibits mouse CYP2A5 and human CYP2A6 activities via different mechanisms
Xiao Deng et al.
ONCOLOGY LETTERS (2016)
The Relation between Hepatotoxicity and the Total Coumarin Intake from Traditional Japanese Medicines Containing Cinnamon Bark
Naohiro Iwata et al.
FRONTIERS IN PHARMACOLOGY (2016)
The allele frequency of CYP2A6*4 in four ethnic groups of China
Cong Pang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Groove binding interaction between daphnetin and calf thymus DNA
Xiaoyue Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)
Interaction of coumarin with calf thymus DNA: Deciphering the mode of binding by in vitro studies
Tarique Sarwar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)
Análisis de frecuencias alélicas y genotípicas de las variantes CYP2A6*12 y rs16969968 de CHRNA5 y su asociación con el hábito de fumar y el índice de masa corporal (IMC) en sujetos jóvenes del noreste de México
Gissela Borrego-Soto et al.
REVISTA MEDICA DE CHILE (2015)
Single-cell microinjection assay indicates that 7-hydroxycoumarin induces rapid activation of caspase-3 in A549 cancer cells
Maribel Soto-Nunez et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Exploring the Usefulness of Botanicals as an Adjunctive Treatment for Lymphedema: A Systematic Search and Review
Ellen G. Poage et al.
PM&R (2015)
In Vitro Assessment of Mutagenic And Genotoxic Effects of Coumarin Derivatives 6,7-Dihydroxycoumarin and 4-Methylesculetin
Edson Luis Maistro et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2015)
Assessment of the genotoxic/clastogenic potential of coumarin derivative 6,7-dihydroxycoumarin (aesculetin) in multiple mouse organs
Eduardo de Souza Marques et al.
TOXICOLOGY REPORTS (2015)
Evaluation of Toxicogenomics Approaches for Assessing the Risk of Nongenotoxic Carcinogenicity in Rat Liver
Johannes Eichner et al.
PLOS ONE (2014)
Biliary Proliferative Lesions in the Sprague-Dawley Rat: Adverse/Non-adverse
James R. Hailey et al.
TOXICOLOGIC PATHOLOGY (2014)
Cassia Cinnamon as a Source of Coumarin in Cinnamon-Flavored Food and Food Supplements in the United States
Yan-Hong Wang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Chemopreventive Potential of Coumarin in 7,12-dimethylbenz[a] anthracene Induced Hamster Buccal Pouch Carcinogenesis
Nagarethinam Baskaran et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Gender Differences in Chemical Carcinogenesis in National Toxicology Program 2-Year Bioassays
Sandeep Kadekar et al.
TOXICOLOGIC PATHOLOGY (2012)
Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System
Kendall S. Frazier et al.
TOXICOLOGIC PATHOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Relative bioavailability of coumarin from cinnamon and cinnamon-containing foods compared to isolated coumarin: A four-way crossover study in human volunteers
Klaus Abraham et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans
Joseph Bloom et al.
PHARMACOGENETICS AND GENOMICS (2011)
Aesculetin-induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway in human cervical cancer cells
Jin Yang et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2010)
Toxicology and risk assessment of coumarin: Focus on human data
Klaus Abraham et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System
Bob Thoolen et al.
TOXICOLOGIC PATHOLOGY (2010)
Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts
Xiaoliang Zhuo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking
Wiratchanee Mahavorasirikul et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Caffeine, caffeine derivatives and chromosomal aberrations
B. A. KIHLMAN et al.
HEREDITAS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo
Nael Al Koudsi et al.
PHARMACOGENOMICS JOURNAL (2009)
Proliferative and Nonproliferative Lesions of the Rat and Mouse Respiratory Tract
Roger Renne et al.
TOXICOLOGIC PATHOLOGY (2009)
A toxicogenomics-based parallelogram approach to evaluate the relevance of coumarin-induced responses in primary human hepatocytes in vitro for humans in vivo
Anne S. Kienhuis et al.
TOXICOLOGY IN VITRO (2009)
Bioenergetic differences selectively sensitize tumorigenic liver progenitor cells to a new gold(I) compound
Matthew M. Jellicoe et al.
CARCINOGENESIS (2008)
Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans
T. Uehara et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2008)
CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives
B. Sinues et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2008)
In vitro study of mutagenic potential of Bidens pilosa Linne and Mikania glomerata Sprengel using the comet and micronucleus assays
Ronaldo de Jesus Costa et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent
Man Ki Ho et al.
PHARMACOGENETICS AND GENOMICS (2008)
A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats
Takeki Uehara et al.
TOXICOLOGY (2008)
Differences in simulated liver concentrations of toxic coumarin metabolites in rats and different human populations evaluated through physiologically based biokinetic (PBBK) modeling
Ivonne M. C. M. Rietjens et al.
TOXICOLOGY IN VITRO (2008)
Nicotine metabolism and CYP2A6 activity in a population of black African descent: Impact of gender and light smoking
Jill C. Mwenifumbo et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays
Russell S. Thomas et al.
TOXICOLOGICAL SCIENCES (2007)
CYP2A6 polymorphisms:: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?
Nicholas Farinola et al.
PHARMACOGENOMICS (2007)
The role of CYP2A6 in the emergence of nicotine dependence in adolescents
Janet Audrain-McGovern et al.
PEDIATRICS (2007)
Comparison of coumarin-induced toxicity between sandwich-cultured primary rat hepatocytes and rats in vivo: A toxicogenomics approach
Anne S. Kienhuis et al.
DRUG METABOLISM AND DISPOSITION (2006)
Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance
Janne Hukkanen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
CYP2A6 polymorphisms in Malays, Chinese and Indians
M. Nurfadhlina et al.
XENOBIOTICA (2006)
A safety assessment of coumarin taking into account species-specificity of toxicokinetics
SP Felter et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais
Sompop Peamkrasatam et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
T-profiler: scoring the activity of predefined groups of genes using gene expression data
A Boorsma et al.
NUCLEIC ACIDS RESEARCH (2005)
Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines
JS Lopez-Gonzalez et al.
LUNG CANCER (2004)
Oral contraceptives induce CYP2A6 activity and accelerate nicotine metabolism.
NL Benowitz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity
JD Vassallo et al.
TOXICOLOGICAL SCIENCES (2004)
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers
M Fujieda et al.
CARCINOGENESIS (2004)
A novel polymorphism of human CYP2A6 gene CTP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo
T Fukami et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Liquid chromatographic determination of the glutathione conjugate and ring-opened metabolites formed from coumarin epoxidation
JD Vassallo et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Comparative metabolism and kinetics of coumarin in mice and rats
SL Born et al.
FOOD AND CHEMICAL TOXICOLOGY (2003)
Concentrations of nine alkenylbenzenes, coumarin, piperonal and pulegone in Indian bidi cigarette tobacco
SB Stanfill et al.
FOOD AND CHEMICAL TOXICOLOGY (2003)
CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6
LB Von Weymarn et al.
XENOBIOTICA (2003)
Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity
M Oscarson et al.
HUMAN MUTATION (2002)
Phenotypic polymorphism of CYP2A6 activity in a Chinese population
P Xu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Studies on the disposition, metabolism and hepatotoxicity of coumarin in the rat and Syrian hamster
BG Lake et al.
FOOD AND CHEMICAL TOXICOLOGY (2002)
Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation
SL Born et al.
DRUG METABOLISM AND DISPOSITION (2002)
Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females
P Ujjin et al.
PHARMACOGENETICS (2002)
An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles
C Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Isoniazid is a mechanism-based inhibitor of cytochrome P-450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes
X Wen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms:: preferential inhibition of cytochrome P4502C9 (CYP2C9)
X Wen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin
FA Jiménez-Orozco et al.
LUNG CANCER (2001)
Lack of effect of coumarin on the formation of micronuclei in an in vivo mouse micronucleus assay
AM Api
FOOD AND CHEMICAL TOXICOLOGY (2001)
CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity
K Kitagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Determination of coumarin metabolism in Turkish population
I Çok et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2001)
The in vivo dermal absorption and metabolism of [4-14C]coumarin by rats and by human volunteers under simulated conditions of use in fragrances
RA Ford et al.
FOOD AND CHEMICAL TOXICOLOGY (2001)
The Ames Salmonella/microsome mutagenicity assay
K Mortelmans et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2000)
In vitro kinetics of coumarin 3,4-epoxidation:: Application to species differences in toxicity and carcinogenicity
SL Born et al.
TOXICOLOGICAL SCIENCES (2000)
CYP2A6: a human coumarin 7-hydroxylase
O Pelkonen et al.
TOXICOLOGY (2000)
Lack of effect of coumarin on unscheduled DNA synthesis in the in vivo rat hepatocyte DNA repair assay
AJ Edwards et al.
FOOD AND CHEMICAL TOXICOLOGY (2000)
Share Paper
